Compounds > o(6)-methyldeoxyguanosine triphosphate
Page last updated: 2024-12-07
o(6)-methyldeoxyguanosine triphosphate
o(6)-Methyldeoxyguanosine triphosphate (o(6)-Me-dGTP) is a modified nucleotide that plays a crucial role in DNA replication and repair. It is formed when the guanine base in deoxyguanosine triphosphate (dGTP) is methylated at the O6 position. This modification is often introduced by alkylating agents, such as those found in tobacco smoke and certain industrial chemicals. o(6)-Me-dGTP is important for research because it can lead to mutations in DNA, as it mispairs with thymine during DNA replication, resulting in transitions from G:C to A:T base pairs. This can contribute to the development of cancer. o(6)-Me-dGTP is also a substrate for DNA repair enzymes, such as O(6)-methylguanine-DNA methyltransferase (MGMT). MGMT removes the methyl group from o(6)-Me-dGTP, preventing mutations. Understanding the role of o(6)-Me-dGTP in DNA replication, repair, and mutagenesis is crucial for developing new therapeutic strategies for cancer prevention and treatment.'
Cross-References
ID Source | ID |
PubMed CID | 115311 |
SCHEMBL ID | 205857 |
MeSH ID | M0081493 |
Synonyms (11)
Synonym |
2'-deoxy-6-o-methoxyguanosine 5'-(tetrahydrogen triphosphate) |
o(6)-methyldeoxyguanosine triphosphate |
guanosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-6-o-methoxy- |
o6-methyldeoxyguanosine triphosphate |
9h-purin-2-amine, 9-(2-deoxy-5-o-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-d-erythro-pentofuranosyl)-6-methoxy- |
ccris 3387 |
63642-16-0 |
[[(2r,3s,5r)-5-(2-amino-6-methoxypurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
SCHEMBL205857 |
9-[2-deoxy-5-o-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)pentofuranosyl]-6-methoxy-3,9-dihydro-2h-purin-2-imine |
DTXSID00979868 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.35 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.29 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |